doi:10.3969/j.issn.1004-583X.2021.10.018

Abstract

CLC Number:

R542.22

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.10.018

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I10/956

References 33

[1]	葛均波, 徐永健, 王辰. 内科学[M].9版. 北京: 人民卫生出版社, 2018: 234.
[2]	Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour[J]. Lancet, 1996,348(9030):771-775. pmid: 8813982
[3]	国家卫生计生委合理用药专家委员会; 中国药师协会. 急性ST段抬高型心肌梗死溶栓治疗的合理用药指南[J]. 中国医学前沿杂志(电子版), 2016,8(8):25-41.
[4]	Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2018,39(2):119-177. doi: 10.1093/eurheartj/ehx393 pmid: 28886621
[5]	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J]. 中华心血管杂志, 2019,47(10):766-783.
[6]	胡盛寿, 高润霖, 刘力生, 等. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019,34(3):209-220.
[7]	Choudhury T, West NE, El-Omar M. ST elevation myocardial infarction[J]. Clin Med (Lond), 2016,16(3):277-282. doi: 10.7861/clinmedicine.16-3-277 pmid: 27251920
[8]	岑惠斌. 急性ST段抬高型心肌梗死静脉溶栓治疗进展[J]. 中外医学研究, 2017,15(18):159-161.
[9]	颜红兵, 向定成, 刘红梅, 等. ST段抬高型急性心肌梗死院前溶栓治疗中国专家共识[J]. 中国介入心脏病学杂志, 2018,26(4):181-190.
[10]	孙冰, 王海昌, 孙东东. 急性ST段抬高型心肌梗死溶栓治疗的最新进展[J]. 心脏杂志, 2020,32(1):93-98.
[11]	王贵鑫. 溶栓药物的药理学研究进展[J]. 血栓与止血学, 2011,17(5):234-236.
[12]	O'Gara PT, Kushner FG, Aschei D, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2013,61(4):e78-e140.
[13]	Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2018,39(2):119-177. doi: 10.1093/eurheartj/ehx393 pmid: 28886621
[14]	Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial[J]. JAMA, 2006,295(13):1519-1530. doi: 10.1001/jama.295.13.joc60038 URL
[15]	宋毓青, 陈威, 胡宏宇, 等. 瑞替普酶及尿激酶静脉溶栓治疗急性心肌梗死的疗效对比[J]. 中国老年学杂志, 2012,32(5):1049-1050.
[16]	张兰芳, 陈春红, 贾新未, 等. 不同溶栓药物治疗急性ST段抬高性心肌梗死的临床疗效对比研究[J]. 临床合理用药杂志, 2013,6(20):5-6.
[17]	李翠萍, 李名亮. 急性ST段抬高型心肌梗死阿替普酶静脉溶栓治疗93例分析[J]. 中国中医药科技, 2014, (z1):176-176.
[18]	吴俊峰. 急性心肌梗死院前和院内溶栓对比分析[J]. 浙江临床医学, 2017,19(9):1690-1691.
[19]	姚蓝, 谢小铭. 急性心肌梗死院前溶栓治疗的Meta分析[J]. 中华急诊医学杂志, 2010,19(8):811-816.
[20]	刘荣魁, 洪波, 郑莹, 等. 尿激酶溶栓治疗急性心肌梗死的疗效及安全性[J]. 中国生化药物杂志, 2016,36(5):189-191.
[21]	窦克非, 王虹剑. 2019年中国成人急性ST段抬高型心肌梗死医疗质量控制报告[J]. 中国循环杂志, 2020,35(4):313-325.
[22]	吕常智. 急性心肌梗死3h内瑞替普酶溶栓与PCI治疗对左心功能影响的对比分析[J]. 中国动脉硬化杂志, 2016,24(5):507-509.
[23]	Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention(ASSENT-4PCI)investigators. Primary versus teneeteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction(ASSENT-4 PCI):randomised trial Intervention(ASSENT-4PCI)investigators.Primary versus teneeteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction(ASSENT-4 PCI):randomised trial[J]. Lancet, 2006,367(9510):569-578. doi: 10.1016/S0140-6736(06)68147-6 URL
[24]	Ellis SG, Armstrong P, Betriu A, et al. Facilitated percutaneous coronary intervention versus primary percutaneous coronary Intervention:Design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events(FINESSE)trial[J]. Am Heart J, 2004,147(4):1-8.
[25]	韩雅玲. 对急性ST段抬高型心肌梗死早期再灌注策略的再认识[J]. 中华心血管病杂志, 2012,40(4):268-270.
[26]	Wijeysundera HC, You JJ, Nallamothu BK, et al. An early invasive strategy versus, ischemia guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: A meta-analysis of contemporary randomized controlled trials[J]. Am Heart J, 2008,156(3):564-572. doi: 10.1016/j.ahj.2008.04.024 pmid: 18760142
[27]	张步春, 周志文, 侯磊, 等. 静脉溶栓联合早期经皮冠状动脉介入治疗急性ST段抬高型心肌梗死的荟萃分析[J]. 中华医学杂志, 2011,91(28):1961-1965.
[28]	Cantor WJ, Fitchett D, Borgundvaag B, et al. Routine early angioplasty after flbrinolysis for acute myocardial infarction[J]. N Engl J Med, 2009,360(26):2705-2718. doi: 10.1056/NEJMoa0808276 URL
[29]	Di Mario C, Dudek D, Piscione F, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the combined abciximab reteplase stent study in acute myocardial infarction(CARESS-in-AMI):an open prospective, randomised, multicentre trial[J]. Lancet, 2008,371(9612):559-568. doi: 10.1016/S0140-6736(08)60268-8 URL
[30]	Bohmer E, Hoffmann P, Abdelnoor M, et al. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction[J]. J Am Coll Cardiol, 2010,55(2):102-110. doi: 10.1016/j.jacc.2009.08.007 URL
[31]	Fazel R, Joseph TI, Sankardas MA, et al. Comparison of reperfusion strategies for ST-segment-elevation myocardial infarction: A multivariate network meta-analysis[J]. J Am Heart Assoc, 2020,9(12):1-9.
[32]	沈珑, 何奔. 溶栓后PCI, 从不行到可行[J]. 医学与哲学, 2010,31(20):35-36, 38.
[33]	万方, 何奔. 急性ST段抬高型心肌梗死溶栓后早期介入治疗效果未必亚于直接介入治疗[J]. 中华心血管病杂志, 2015,43(3):274-276.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 33

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhang Canna, Xiang Lu, Luo Yaxiong. Electrocardiographic findings of the spiked helmet sign: A case report and literature review [J]. Clinical Focus, 2023, 38(5): 444-447.
[2]	Yan Haiyan, Ding Yankui, JiaHongjing , WangJiyuan , Zhang Xuewei, Hu Yinjie, Chu Junjie, Hu Hongyan, Guo Gaofeng. Correlation of pre-hospital heparinization combined with one pack of drugs and revascularization in patients with acute ST-segment elevation myocardial infarction [J]. Clinical Focus, 2023, 38(3): 232-236.
[3]	Li Nana, Jiang Shan. Predictive values of serum homocysteine, cystatin C and high sensitive C-reactive protein levels on heart failure after percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction [J]. Clinical Focus, 2023, 38(2): 121-125.
[4]	Wang Jiaqi, Gao Man, Zhang Feifei, Li Yingxiao, Dang Yi, Qi Xiaoyong. Predicting value of neutrophil to lymphocyte ratio combined with GRACE score on in-hospital major adverse cardiovascular events of postoperative PCI in acute STEMI patients [J]. Clinical Focus, 2022, 37(5): 412-417.
[5]	Shi Jun, Liu Xinbing, Bai Yanyan, Yue Dandan, Wang Xiaoqing, Liu Tianhua, Feng Liuliu. Influencing factors of myocardial microcirculation perfusion disorder after percutaneous coronary intervention in acute myocardial infarction and relationship with lactic acid [J]. Clinical Focus, 2021, 36(5): 402-407.
[6]	He Na, Li Minxian, Zhang Qi, Xu Fang, Zhang Chenfeng, Song Da. Effects of Tongxinluo Capsules on myocardial microperfusion in patients free of reflow after PCI and long-term efficacy and safety [J]. Clinical Focus, 2021, 36(2): 129-133.
[7]	Luo Kaifeng, Feng Chuanjie. The factors influencing the prognosis of STsegment elevation myocardial infarction after coronary intervention A meta analysis [J]. Clinical Focus, 2020, 35(12): 1067-1077.
[8]	. [J]. Clinical Focus, 2016, 31(3): 340-341.
[9]	Hu Fuli;Wang Tianhong;Liu Meixia;Yuan Huabing;Ni Yanhui;Cao Guangyun;Zhang Qingfen;Yuan Jing;Xu Yufang;Wang Wenjing. Antiplatelet drug resistance induced subacute coronary stent thrombosis:two cases report and literature review [J]. Clinical Focus, 2015, 30(12): 1352-1355.
[10]	Dai Gongqiang;Xiao Dongmei;Ding Huaisheng;Liu Haiyan;Li Yuan. Effects of rosuvastatin calcium on neural remodeling and ventricular fibrillation threshold in rats with myocardial infarction combined with hyperlipemia [J]. Clinical Focus, 2015, 30(11): 1303-1306.
[11]	Wang Yanbo;Gu Xinshun;Hao Guozhen;Li Wei;Xing Kun;Geng Wei;Fu Xianghua. Major adverse cardiac events in patients of ST-segment elevation infarction with pulmonary hypertension [J]. Clinical Focus, 2015, 30(7): 751-754.
[12]	Sun Shikun;Li Nanyang;Li Xun. Predictive value of body surface electrocardiogram in distinguishing infarct-related artery and location of occlusion in patients with acute inferior wall myocardial infarction [J]. Clinical Focus, 2015, 30(5): 495-498.
[13]	. [J]. Clinical Focus, 2015, 30(5): 587-590.
[14]	. [J]. Clinical Focus, 2015, 30(4): 436-438439.
[15]	. [J]. Clinical Focus, 2015, 30(4): 439-442.